Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Grand Rapids
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Grand Rapids, MI

Studies commonly pay $75 to $4,500 per completed study

458 clinical trials are currently recruiting participants within 30 miles of Grand Rapids. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

458studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Grand Rapids right now

Top 25 of 458 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems

Clavicle, Acromioclavicular Joint N/A Observational 76 participants sought
Corewell Health — Grand Rapids, Michigan (0.6 mi) · Sponsor: AO Innovation Translation Center
See eligibility & contact on ClinicalTrials.gov (NCT04921865)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011) — Grand Rapids, Michigan (0.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Grand Rapids, Michigan (0.6 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Relapsed/Refractory Multiple Myeloma Phase 2 Interventional 100 participants sought
START Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: C4 Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284758)

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

Systemic Lupus Erythematosus of Childhood (Disorder) N/A Interventional 175 participants sought
Helen Devos Children's Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: Michigan State University
See eligibility & contact on ClinicalTrials.gov (NCT06232304)

E-Mindfulness Approaches for Living After Breast Cancer

Breast Cancer, Depression Phase 3 Interventional 402 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06748222)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center — Wyoming, Michigan (4.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma Phase 1 Interventional 174 participants sought
START Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: Avacta Life Sciences Ltd
See eligibility & contact on ClinicalTrials.gov (NCT07454642)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Cancer Research Consortium of West Michigan — Grand Rapids, Michigan (0.6 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Helen DeVos Children's Hospital at Spectrum Health — Grand Rapids, Michigan (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy

Fuchs Endothelial Corneal Dystrophy, Fuchs Phase 2 Interventional 28 participants sought
DTX-168-201 Study Site — Grand Rapids, Michigan (0.6 mi) · Sponsor: Design Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07024693)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Grand Rapids, Michigan (0.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 143 participants sought
Gastroenterology Associates of Western Michigan, P.L.C. — Wyoming, Michigan (4.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06598943)

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Relapsed/Refractory Acute Myeloid Leukemia Phase 1 Interventional 120 participants sought
START Midwest/The Cancer and Hematology Center — Grand Rapids, Michigan (0.6 mi) · Sponsor: SystImmune Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06714591)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought
Galderma Investigational Site 7108 — Grandville, Michigan (6.5 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT06988605)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)
Actively enrolling

Studies you may be able to join near Grand Rapids

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Grand Rapids

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MSU Grand Rapids Research Center

★ 4.9 (9 reviews)
400 Monroe Ave NW, Grand Rapids, MI 49503
(616) 234-0970
"My husband is receiving treatment there and everyone helping us was fantastic."
— Margaret Ross, 5★

Cancer Research Consortium of West Michigan

25 Michigan St NE, Grand Rapids, MI 49503
(616) 391-1230

West Michigan Clinical Research Center

2093 Health Dr SW Ste 201, Wyoming, MI 49519
(616) 328-5344

Imperial Clinical Research Services

★ 4.7 (9 reviews)
3100 Walkent Dr NW, Grand Rapids, MI 49544
(800) 777-2591

Beat Childhood Cancer Research Consortium

Grand Rapids, MI 49503
(616) 375-9169

BAMF Health

★ 4.9 (32 reviews)
109 Michigan St NW, Grand Rapids, MI 49503
(888) 981-2263
"Just had a couple MRI's done this afternoon. I can't say enough for the excellent service and care they provided. From valet parking to a clean and…"
— Kevin DeVisser, 5★

The Cancer & Hematology Centers

★ 4.9 (608 reviews)
145 Michigan St NE #3100, Grand Rapids, MI 49503
(616) 954-9800
"Doctor Vanderwoude is a kind caring Dr that goes out of her way to care for her patients."
— Tina Miles, 3★

Corewell Health Graduate Medical Education

945 Ottawa Ave NW, Grand Rapids, MI 49503
(616) 732-6200

Vivid IV Health

★ 5.0 (252 reviews)
38 Commerce Ave SW, Grand Rapids, MI 49503
(616) 350-9123

Clinical trials in Grand Rapids: what's recruiting

The Grand Rapids area currently has 458 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Grand Rapids, the most active research areas are:

  • Cancer & Oncology17 studies
  • Immune & Skin4 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Grand Rapids, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Grand Rapids

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Grand Rapids participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Grand Rapids pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Grand Rapids safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Grand Rapids, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Grand Rapids?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Grand Rapids.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Rapids typically complete one or two studies per year.

Paid clinical trials near Grand Rapids

Other metros within reach

Muskegon, MI60 Kalamazoo, MI106 Lansing, MI178 Elkhart, IN110 South Bend, IN110 Fort Wayne, IN115 Flint, MI175 Ann Arbor, MI1,172

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Grand Rapids Bladder Issues Due To Spinal Cord Injury in Grand Rapids All conditions

More of MI

South Lyon1,319 Detroit1,197 Ann Arbor1,172 Lansing178 Flint175 Kalamazoo106 Muskegon60

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts